Adults with moderately to severely active Crohn disease can now self-administer risankizumab induction at home using an ...

HealthDay News — Early uptake was rapid for oral semaglutide (Wegovy pill) relative to injectable incretin-based weight ...

HealthDay News — Medical device adverse event reports are frequently incomplete, inaccurate, and delayed, according to a study published online October 14 in The BMJ.

The investigational vaccine targets pathological amyloid-beta to lower brain amyloid in patients with preclinical Alzheimer ...

The new 150mg oral pellet formulation provides a capsule-free prophylactic option for adults and adolescents with hereditary ...

Patients with baseline viral suppression maintained viral suppression, while those without achieved viral suppression by 13 ...

Mean percentage of time that CGM-measured glucose level was in range of 70 to 180mg/dL was 21 percentage points higher with CGM ...

The FDA has approved the first generic equivalent of Climara Pro, offering a once-weekly transdermal option for managing moderate to severe vasomotor symptoms and preventing postmenopausal ...

HealthDay News — Antipsychotic treatment initiation is associated with rapid increases in hemoglobin A1c (HbA1c) and weight, according to a study published in the November issue of The Lancet ...

Strong recommendations include distinguishing bothersome from nonbothersome tinnitus, asking about risks for self-harm.

Accelerated approval is supported by 34-week interim data from the phase 3 I CAN trial showing a statistically significant 43% placebo-adjusted reduction in proteinuria.

A new liquid formulation of cevimeline HCl offers a bioequivalent alternative for adult patients experiencing dry mouth ...